This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Vocera Chief Medical Officer Bridget Duffy Keynotes At Top Global Health Conferences

Stocks in this article: VCRA

SAN JOSE, Calif., June 10, 2013 /PRNewswire/ -- Vocera Communications, Inc. (NYSE: VCRA), the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced that M. Bridget Duffy, M.D., chief medical officer at Vocera will keynote at two upcoming top global health conferences. At both events, Dr. Duffy will explain why now is the time for organizations to create an experience-based culture that restores the joy to medicine and will outline how to use technology to close gaps in patient communication. Dr. Duffy will draw on her experience as the nation's first chief experience officer to explore the connection between quality, safety and patient experience.

(Logo:  http://photos.prnewswire.com/prnh/20120711/MM39184LOGO)

Dr. Duffy will speak at the following conferences in June:

  • Canadian College of Health Leaders Conference ( Niagara Falls, Ontario; June 10 - 11, 2013) is Canada's largest gathering of health system decision makers, including trustees, chief executive officers, directors, managers and department heads. Dr. Duffy will deliver her keynote: "Leadership for Person and Family-Centered Health Systems," at 9:00 a.m. EDT on Tuesday, June 11, 2013.  
  • HIMSS Europe's La Revolution Numerique  ( Strasbourg, France; June 18 - 19, 2013) is HIMSS Europe's first mini CIO Summit in France, solely dedicated to French speaking CIOs. Dr. Duffy will deliver her keynote: "Humanizing the Delivery of Medical Technology," at 2:45 p.m. CET on Tuesday, June 18, 2013.

M. Bridget Duffy, M.D., is the chief medical officer of Vocera. Prior to joining Vocera, she served as the founder and CEO of ExperiaHealth and as chief experience officer of the Cleveland Clinic, the first senior position of its kind in the nation, where she led the institution in establishing patient experience as its top strategic priority. She is a frequent speaker on the subject of why the patient experience matters and how it impacts clinical outcomes. Her work has earned her the Quantum Leap Award for taking the risk to spur internal change in her field and has led her to be featured in HealthLeaders magazine as one of "20 People Who Make Healthcare Better." Dr. Duffy attended medical school at the University of Minnesota. She completed her residency in internal medicine at Abbott Northwestern Hospital in Minneapolis, Minn., where she created and served as medical director for one of the first "hospitalist" services in the country. Dr. Duffy also served as medical director of Medtronic, Inc.

About Vocera Communications

Vocera is the leading provider of mobile communication solutions that address critical productivity and safety challenges facing healthcare, hospitality, retail and other mobile work environments. One of the fastest growing mobile technology companies, Vocera is widely recognized for developing smarter ways to communicate that improve patient and customer satisfaction. Exclusively endorsed by the American Hospital Association, Vocera® Voice Communication, Secure Messaging, and Patient Experience solutions are installed in more than 1,000 organizations worldwide. Vocera is headquartered in San Jose, Calif., with offices in Tennessee, Canada, and the United Kingdom. For more information, visit www.vocera.com and @VoceraCom on Twitter.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs